Immunome Inc is a biopharmaceutical company... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
IMNM is expected to report earnings to fall 39.41% to -67 cents per share on May 08
Q1'25
Est.
$-0.67
Q4'24
Missed
by $0.45
Q3'24
Missed
by $0.24
Q2'24
Missed
by $0.22
Q1'24
Missed
by $1.83
The last earnings report on March 19 showed earnings per share of -111 cents, missing the estimate of -66 cents. With 552.87K shares outstanding, the current market capitalization sits at 542.57M.